Ultralife (ULBI) to Release Earnings on Monday

Ultralife (NASDAQ:ULBI) will likely be releasing its Q4 2025 results before the market opens on Monday, February 23rd. Analysts expect Ultralife to post earnings of $0.24 per share and revenue of $57.00 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, February 26, 2026 at 7:00 AM ET.

Ultralife Stock Performance

Shares of NASDAQ ULBI opened at $5.87 on Friday. The company has a market cap of $97.74 million, a P/E ratio of 58.70 and a beta of 0.88. Ultralife has a 52-week low of $4.07 and a 52-week high of $9.52. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.42 and a current ratio of 2.99. The firm’s fifty day moving average is $6.16 and its two-hundred day moving average is $6.40.

Insider Activity

In other Ultralife news, Director Bradford T. Whitmore purchased 28,588 shares of the stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average price of $5.70 per share, with a total value of $162,951.60. Following the acquisition, the director owned 1,235,631 shares in the company, valued at approximately $7,043,096.70. The trade was a 2.37% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders have bought 54,750 shares of company stock worth $310,760. 40.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Ultralife

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ULBI. Empowered Funds LLC bought a new stake in shares of Ultralife in the 4th quarter valued at approximately $44,000. XTX Topco Ltd raised its holdings in Ultralife by 19.9% during the 4th quarter. XTX Topco Ltd now owns 15,456 shares of the technology company’s stock valued at $88,000 after buying an additional 2,569 shares during the period. Rothschild Wealth LLC purchased a new stake in Ultralife during the 4th quarter valued at $400,000. Heron Bay Capital Management bought a new stake in Ultralife in the fourth quarter worth $127,000. Finally, Jane Street Group LLC purchased a new position in Ultralife during the fourth quarter worth $75,000. 30.68% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ultralife in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.